HYBRIGEN

Hybrigen, Inc.

Application Filed: 2001-02-19

Trademark Application Details

Mark For: HYBRIGEN® trademark registration is intended to cover the categories of developing proteomic platform technologies on behalf of pharmaceutical, biotechnology and agribusiness companies, namely, developing new processes by which high value drug targets might be discovered which in turn can be used by pharmaceutical, biotechnology and agribusiness companies for new drug development activities; and helping pharmaceutical, biotechnology and agribusiness companies accelerate discovery and development of promising new drugs. [all]

Status

2022-09-10 UTC

DEAD REGISTRATION Cancelled Invalidated

The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.

Research	OneLook Acronym Finder
Serial Number	76213709
Registration Number	2512556
Mark Literal Elements	HYBRIGEN
Mark Drawing Type	1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Type	SERVICE MARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	TTAB 2008-04-29
Basis	1(a)
Class Status	SECTION 18 - CANCE
Primary US Classes	100: Miscellaneous 101: Advertising and Business
Primary International Class	042 - Primary Class (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed Use	Yes
Current Use	Yes
Intent To Use	No
Filed ITU	No
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	3
Attorney Name	Anita Nesser
Attorney Docket Number	068660.0110
Law Office Assigned	L70
Employee Name	SALEMI, DOMINICK J

Timeline

1997-00-00	Date of First Use
1997-09-09	Date of First Use
1998-11-01	Date of Use In Commerce
2001-02-19	Application Filed
2001-09-04	Published
2001-09-04	Published for Opposition
2001-11-27	Trademark Registered
2008-04-29	Cancelled
2008-04-29	Location: TTAB
2008-04-29	Status: Dead/Cancelled
2008-04-29	Status: Registration cancelled under Section 18 by the Trademark Trial and Appeal Board. For further information, see TTABVUE on the Tra
2018-07-08	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	Hybrigen, Inc.
Address	2723 Irving Boulevard Dallas, TEXAS UNITED STATES 75207
Legal Entity Type	Corporation
Legal Entity State	TEXAS

Documents

Application		2001-02-19
Drawing		2001-02-19
Specimen		2001-02-19
Registration Certificate		2001-11-27
Registration Certificate		2001-11-27
File Jacket		2007-01-04
Specimen		2007-01-04
Unclassified		2007-01-04

Attorney of Record

Hybrigen, Inc.
2723 Irving Boulevard
Dallas, TX 75207

Good, Services, and Codes

(CANCELLED)
IC 042. US 100 101. G & S: DEVELOPING PROTEOM
IC PLATFORM TECHNOLOGIES ON BEHALF OF PHARMACEUTICAL, BIOTECHNOLOGY AND AGRIBUSINESS COMPANIES, NAMELY, DEVELOPING NEW PROCESSES BY WHICH HIGH VALUE DRUG TARGETS MIGHT BE DISCOVERED WHICH IN TURN CAN BE USED BY PHARMACEUTICAL, BIOTECHNOLOGY AND AGRIBUSINESS COMPANIES FOR NEW DRUG DEVELOPMENT ACTIVITIES; AND HELPING PHARMACEUTICAL, BIOTECHNOLOGY AND AGRIBUSINESS COMPANIES ACCELERATE DISCOVERY AND DEVELOPMENT OF PROMISING NEW DRUGS. FIRST USE: 19970000. FIRST USE IN COMMERCE: 19981100

International Codes:	42
U.S. Codes:	100,101

Type Code	Type
GS0421	DEVELOPING PROTEOMIC PLATFORM TECHNOLOGIES ON BEHALF OF PHARMACEUTICAL, BIOTECHNOLOGY AND AGRIBUSINESS COMPANIES, NAMELY, DEVELOPING NEW PROCESSES BY WHICH HIGH VALUE DRUG TARGETS MIGHT BE DISCOVERED WHICH IN TURN CAN BE USED BY PHARMACEUTICAL, BIOTECHNOLOGY AND AGRIBUSINESS COMPANIES FOR NEW DRUG DEVELOPMENT ACTIVITIES; AND HELPING PHARMACEUTICAL, BIOTECHNOLOGY AND AGRIBUSINESS COMPANIES ACCELERATE DISCOVERY AND DEVELOPMENT OF PROMISING NEW DRUGS

Type Code

Type

GS0421

DEVELOPING PROTEOMIC PLATFORM TECHNOLOGIES ON BEHALF OF PHARMACEUTICAL, BIOTECHNOLOGY AND AGRIBUSINESS COMPANIES, NAMELY, DEVELOPING NEW PROCESSES BY WHICH HIGH VALUE DRUG TARGETS MIGHT BE DISCOVERED WHICH IN TURN CAN BE USED BY PHARMACEUTICAL, BIOTECHNOLOGY AND AGRIBUSINESS COMPANIES FOR NEW DRUG DEVELOPMENT ACTIVITIES; AND HELPING PHARMACEUTICAL, BIOTECHNOLOGY AND AGRIBUSINESS COMPANIES ACCELERATE DISCOVERY AND DEVELOPMENT OF PROMISING NEW DRUGS

Trademark Filing History

Description	Date	Proceeding Number
CANCELLED SECTION 18-TOTAL	2008-04-29
CANCELLATION TERMINATED NO. 999999	2008-04-29	48088
CANCELLATION GRANTED NO. 999999	2008-04-03	48088
CANCELLATION INSTITUTED NO. 999999	2007-09-11	48088
CASE FILE IN TICRS	2007-01-05
REGISTERED-PRINCIPAL REGISTER	2001-11-27
PUBLISHED FOR OPPOSITION	2001-09-04
NOTICE OF PUBLICATION	2001-08-15
APPROVED FOR PUB - PRINCIPAL REGISTER	2001-07-11
ASSIGNED TO EXAMINER	2001-07-05	62178

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
HYBRIGEN 86265324 5263188 Live/Registered	KYUNGDONG NAVIEN CO., LTD. 2014-04-29
HYBRIGEN 85371558 4617845 Live/Registered	BAE Systems Controls Inc. 2011-07-14
HYBRIGEN 76213709 2512556 Dead/Cancelled	Hybrigen, Inc. 2001-02-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.